On this evening, all proceeds from the play “Men come from Mars, women from Venus”, performed by Xavier Viton, will be donated to the Liryc. The price is set at 49 euros. Friday, May 6th, there were still a few places left.
Raising funds through a show is a first for the Liryc. This institute, which specializes in cardiac rhythmology and is based in the Xavier Arnozan Hospital in Pessac, usually prefers gala dinners. However, self-funding is a limitation. “Our annual operating budget is approximately €11 million,” explains Élodie Gaillacq, Communications Manager. We are supported by CHU, University, Inria, Region and State whose endowment is 5 million but we know it needs to be reduced. »
A funding initiative was therefore launched three years ago, which is intended to collect 10 million euros by 2024. These funds are intended to help research in the fight against strokes (cerebral vascular infarction), heart failure and the resulting sudden cardiac death when the heart’s electrical supply collapses, which almost cost the life of Danish footballer Christian Eriksen during last summer’s European Championship.
Professor Michel Haïssaguerre, founder of the Institute, is expected to be eligible for the Nobel Prize for his discovery of a treatment for atrial fibrillation
“We are the only facility in the world that specializes in these three pathologies,” continues Élodie Gaillacq. 160 employees work at Liryc, including cardiologists from the university hospital, which allows us to keep a direct line to the problems of the patients. Professor Michel Haïssaguerre, founder of the Institute, is also being challenged for the Nobel Prize for his discovery of a treatment for atrial fibrillation (which occurs when the heart’s electrical activity becomes irregular), used by more than 400,000 people worldwide every year.
recognize risks better
The next advances could be in the field of medical imaging, with the development of a type of clothing that the patient would wear. It would make it possible to perform an electrocardiogram without the application of electrodes and to better identify the risks of sudden cardiac death.